Fabián A. Dávila
Grupo México
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fabián A. Dávila.
Biomedica | 2017
Sandra Milena Gualtero; Lina Alejandra Abril; Nathalia Camelo; Susi Daniela Sanchez; Fabián A. Dávila; Gerson Arias; Edwin Silva; Ingrid Gissel Bustos; Diego Fernando Josa; Isabel Cristina Torres; Luis Carlos Zambrano; María José Pareja
INTRODUCTION Clostridium difficile is the main pathogen related to healthcare-associated diarrhea and it is the cause of 20 to 30% of diarrhea cases caused by antibiotics. In Colombia and Latin America, the knowledge about the epidemiological behavior of this infection is limited. OBJECTIVE To describe the characteristics of a series of patients with C. difficile infection. MATERIALS AND METHODS We performed a descriptive case series study of patients with C. difficile infection hospitalized in the Fundación Clínica Shaio from January, 2012, to November, 2015. RESULTS We analyzed 36 patients. The average age was 65 years. The risk factors associated with the infection were: previous use of antibiotics (94.4%), prior hospitalization in the last three months (66.7%) and use of proton pump inhibitors (50%). The most common comorbidities were chronic kidney disease (41.7%) and diabetes mellitus (30.6%). The most frequent symptoms were more than three loose stools per day (97.1%) and abdominal pain (42.9%). According to the severity of the disease, 44.4% of cases were classified as mild to moderate, 38.9% as severe, and 11.1% as complicated or severe. The detection of the toxin by PCR (GeneXpert) was the most common diagnostic procedure (63.8%). Global mortality during hospitalization was 8%. We identified four strains with serotype NAP1/027 and nine samples positive for binary toxin. CONCLUSION Clostridium difficile infection should be suspected in patients with diarrhea and traditional risk factors associated with this disease. We report the circulation of the hypervirulent strain serotype NAP1/027 in Colombia, which should be countered with epidemiological surveillance and a prompt diagnosis.
Biomedica | 2016
Sandra Gualtero; Lina Alejandra Abril; Nathalia Camelo; Susi Daniela Sanchez; Fabián A. Dávila; Gerson Arias; Edwin Silva; Ingrid Gissel Bustos; Diego Fernando Josa; Isabel Cristina Torres; Luis Carlos Zambrano; Maria J. Pareja
INTRODUCTION Clostridium difficile is the main pathogen related to healthcare-associated diarrhea and it is the cause of 20 to 30% of diarrhea cases caused by antibiotics. In Colombia and Latin America, the knowledge about the epidemiological behavior of this infection is limited. OBJECTIVE To describe the characteristics of a series of patients with C. difficile infection. MATERIALS AND METHODS We performed a descriptive case series study of patients with C. difficile infection hospitalized in the Fundación Clínica Shaio from January, 2012, to November, 2015. RESULTS We analyzed 36 patients. The average age was 65 years. The risk factors associated with the infection were: previous use of antibiotics (94.4%), prior hospitalization in the last three months (66.7%) and use of proton pump inhibitors (50%). The most common comorbidities were chronic kidney disease (41.7%) and diabetes mellitus (30.6%). The most frequent symptoms were more than three loose stools per day (97.1%) and abdominal pain (42.9%). According to the severity of the disease, 44.4% of cases were classified as mild to moderate, 38.9% as severe, and 11.1% as complicated or severe. The detection of the toxin by PCR (GeneXpert) was the most common diagnostic procedure (63.8%). Global mortality during hospitalization was 8%. We identified four strains with serotype NAP1/027 and nine samples positive for binary toxin. CONCLUSION Clostridium difficile infection should be suspected in patients with diarrhea and traditional risk factors associated with this disease. We report the circulation of the hypervirulent strain serotype NAP1/027 in Colombia, which should be countered with epidemiological surveillance and a prompt diagnosis.
Urología Colombiana | 2017
Fabián A. Dávila; Maria J. Pareja; Eduar S. Rodríguez; William R. Fajardo; Rubén Daniel Luna; Karen V. Flórez
Revista Colombiana de Endocrinología, Diabetes & Metabolismo | 2017
Oscar Medina; Rubén Daniel Luna; Karen Pardo; Fabián A. Dávila
Revista Colombiana de Endocrinología, Diabetes & Metabolismo | 2017
Oscar Medina; Juan Manuel Sarmiento; Larry Quinn; Sonia Merlano; Fabián A. Dávila; Andrés Felipe Barragán; Antonio José Lewis; Iván René Mogollón; Maria J. Pareja
Revista Colombiana de Cardiología | 2017
Fabián A. Dávila; Luis Alberto Barros; Jorge Reynolds; Antonio José Lewis; Iván René Mogollón
Revista Colombiana de Cardiología | 2017
Fabián A. Dávila; Antonio José Lewis; Iván René Mogollón; Fernán Mendoza; Diego A. Guatibonza
Revista Argentina de Anestesiología | 2017
Fabián A. Dávila; Gildardo Roncancio; Andrés Robayo; David Benavides; Natalia Nevado Ardila
Neurología Argentina | 2017
Javier Torres Zafra; Carlos Roa Mejia; Andres Fonnegra; Gina Cajicá Martínez; Felipe Arturo Sandoval; Fabián A. Dávila; Iván René Mogollón
Cardiocore | 2017
Gustavo Palomino; Maria J. Pareja; Maria C. Pareja; Natalia Nevado; Fernán Mendoza; Fabián A. Dávila; Claudia Jaramillo